Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired (Tables)

v3.19.1
Licenses Acquired (Tables)
3 Months Ended
Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Research and Development Arrangement, Contract to Perform for Others As such, for the three months ended March 31, 2019 and 2018, the purchase price of licenses acquired was classified as research and development-licenses acquired in the Condensed Consolidated Statements of Operations as reflected in the table below:
 
 
For the Three Months Ended March 31,
 
($ in thousands)
 
2019
 
 
2018
 
Partner companies:
 
 
 
 
 
 
 
 
Helocyte
 
$
 
 
$
21
 
Mustang
 
 
450
 
 
 
75
 
Cellvation
 
 
 
 
 
1
 
Total
 
$
450
 
 
$
97
 
Schedule Of Licenses Acquired Expenses
For the three months ended March 31, 2019 and 2018, Mustang recorded the following expense in research and development for licenses acquired:
 
 
 
For the Three Months Ended March 31,
 
($ in thousands)
 
2019
 
 
2018
 
City of Hope (COH) – CD123
 
$
250
 
 
 
City of Hope manufacturing
 
 
 
 
 
75
 
Nationwide Children’s Hospital – C134 (MB-108)
 
 
200
 
 
 
 
Total
 
$
450
 
 
$
75